Pariveda Drugs & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.06%
- Profit Growth 65.96%
- Ebitda 11.36%
- Net Worth 22.51%
- Total Assets 36.46%
About Pariveda Drugs & Pharmaceuticals
Pariveda Drugs & Pharmaceuticals Private Limited (PDPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 August 2013 and has a history of 11 years and five months. Its registered office is in Chandrapur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkateshwar Pariveda, Venkateswara Nagineni, and Rohith Pariveda serve as directors at the Company.
Company Details
- Location
Chandrapur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51101MH2013PTC247055
- Company No.
247055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pariveda Drugs & Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohith Pariveda  | Director | 20-Dec-2017 | Current |
| Venkateshwar Pariveda | Director | 16-Aug-2013 | Current |
| Venkateswara Nagineni | Director | 03-Oct-2016 | Current |
Financial Performance of Pariveda Drugs & Pharmaceuticals.
Pariveda Drugs & Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.06% decrease. The company also saw a substantial improvement in profitability, with a 65.96% increase in profit. The company's net worth Soared by an impressive increase of 22.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pariveda Drugs & Pharmaceuticals?
In 2019, Pariveda Drugs & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sv Knowledge Konnect Services Private LimitedVenkateswara Nagineni is a mutual person
- Tanushree Consultants Private Limited
Venkateswara Nagineni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pariveda Drugs & Pharmaceuticals?
Unlock and access historical data on people associated with Pariveda Drugs & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pariveda Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pariveda Drugs & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
